Five months after giving up on its lead drug Betalutin for follicular lymphoma, Nordic Nanovector has charted a course forward via a merger with fellow Norwegian biotech APIM Therapeutics. The merger ...
Iran Blockade Sets Up a Test of Which Side Can Endure More Pain President Trump wants to choke off Tehran’s lifeline by blocking the Strait of Hormuz. But Iran is betting his tolerance for political ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results